Drug Search Results

Mericitabine

Alternative Names: mericitabine, ro-5024048, ro5024048, ro 5024048
Latest Update: 2024-05-15
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: HCV-NS5B Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Hoffmann-La Roche
Company Location: BASEL SWITZERLAND V8
Company CEO: Severin Schwan
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Mericitabine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hepatitis A|Hepatitis C, Chronic|Hepatitis C

Phase 1: Healthy Volunteers|Hepatitis C, Chronic|Hepatitis A

Trial	Phase	Trial Status	Disease	Primary Completion Date
NV22877	P2	Withdrawn	Hepatitis C, Chronic	2014-03-01
2011-002714-37	P2	Completed	Hepatitis C, Chronic	2014-02-04
NV27779	P2	Completed	Hepatitis A\|Hepatitis C, Chronic	2014-01-31
2011-002715-28	P2	Completed	Hepatitis C, Chronic	2014-01-30

Recent News Events

Date	Type	Title
05/15/2024	PubMed	Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV-1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study.
05/13/2024	PubMed	Characteristics and rates of infection by HIV in people receiving non-occupational post-exposure prophylaxis (nPEP) against HIV.
05/10/2024	PubMed	Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions